20 Sept. | 09:00 - 10:30 |
YOUNGINNOVATION | HEALTH & NANOMEDICINE | ||||||
THE STATE OF RESEARCH COMMUNICATED BY YOUNG RESEARCHERS | |||||||
TT.I - Technical Multi-Track with Parallel SYMPOSIA | |||||||
Exploring the Future: Advances in 3D Bioprinting for Tissue Engineering and Regenerative Medicine | |||||||
Co-organized with University Magna Graecia of Catanzaro and Sapienza University of Rome Chair: Michele CONTI, University of Pavia |
|||||||
This revolutionary technique allows for the precise printing of cells, biocompatible materials, scaffolds or support structures, and growth factors promoting cell growth and the formation of new tissues or organs. The primary goal of 3D-bioprinting is to address the growing shortage of organs for transplantation and find solutions for tissue repair. The advantages of 3D-Bioprinting applied to medicine and research fields are numerous, such as the possibility to obtain a personalized therapy creating tissues that mimic a patient's unique biology and creating patient-specific tissues and organs, tailored to individual needs; the disease modeling for a deeper understanding of disease mechanisms and the development of more effective treatments or to study rare and complex diseases that are challenging to replicate in traditional cell cultures, providing insights into their underlying mechanisms; moreover bioprinted tissues can serve as alternatives to animal testing, reducing the ethical concerns associated with animal experimentation while providing more relevant data for human health. Despite these and other advantages, there are significant challenges to overcome, such as the complexity of biological structures and the need to develop biocompatible and safe materials for use in 3D-bioprinting. Nevertheless, the field of 3D-bioprinting is rapidly evolving, with researchers and companies working to refine the technology and move it from experimental phases to practical applications in medicine and science. | |||||||
The symposium is part of the Special Event SE.I |
|||||||
TT.I.F.1 SE.I.1.1 |
Introductive Keynote Carmine GENTILE University of Technology, Sydney, Australia Bioengineering the human cardiac microenvironment uing patient- derived cardiac spheroid and 3D bioprinting technologies |
||||||
TT.I.F.2 SE.I.1.2 |
Giuseppe Francesco RACANIELLO University 'Aldo Moro' of Bari Production of solide dosage forms via Direct Powder Extrusion 3D Printing |
||||||
TT.I.F.3 SE.I.1.3 |
Pier Francesco GAZIANO University of Tor Vergata, Rome Cells in bioprinted hydrogel structures: insights from models and simulations |
||||||
TT.I.F.4 SE.I.1.4 |
Elena DELGROSSO - CV Univeristy of Pavia 3D Bioprinting to Develop Neoplastic Biological Constructs for Experimental Boron Neutron Capture Therapy (BNCT) Applications |
||||||
TT.I.F.5 SE.I.1.5 |
Michele MARINO - CV University of Tor Vergata, Rome An eye in bioprinted scaffolds: from instrumented tissue models to digital twinss |
||||||
Back to Fields & Topics | Back to Plan 20 September | ||